MedPath

MRI of the breast for optimal selection of patients with a preoperative diagnosis of ductal carcinoma in situ for a sentinel node biopsy procedure

Recruiting
Conditions
breast preneoplasia
ductal carcinoma in situ
10006291
Registration Number
NL-OMON36570
Lead Sponsor
Albert Schweitzer Ziekenhuis
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
150
Inclusion Criteria

Women > 25 years of age with biopsy proven DCIS are eligible for this study.

Exclusion Criteria

• claustrophobia, obesity (too big to fit into gantry of the MR system), large breast cup size (too big to fit into the coil)
• pacemaker
• known inflammatory diseases (RA, SLE, sarcoidosis, psoriasis) since these can cause reactive axillary lymfadenopathy
• pregnancy
• biopsy proven invasive carcinoma in the same breast; invasive carcinoma in the contra lateral breast is not an exclusion criterion.
• poor health excluding an operative procedure
- renal failure

Study & Design

Study Type
Observational invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>Predictive value of MRI and selected tissue markers on the presence of IDC</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>Accuracy of MRI in determining the extent of DCIS compared to mammography. The<br /><br>size as determined by pathological examination will be the gold standard</p><br>
© Copyright 2025. All Rights Reserved by MedPath